China’s FDA Verifies Data from 55 Clinical Trials in First Audits

International Pharmaceutical Regulatory Monitor
A A
As part of its clinical trial data auditing initiative, the Chinese Food and Drug Administration verified data from an initial set of 55 clinical trials, focusing mainly on large, international drugmakers.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor